The Medical Segmentation Decathlon

Michela Antonelli(King's College London), Annika Reinke(German Cancer Research Center), Spyridon Bakas(University of Pennsylvania), Keyvan Farahani(National Cancer Institute), Annette Kopp‐Schneider(German Cancer Research Center), Bennett A. Landman(Vanderbilt University), Geert Litjens(Radboud University Nijmegen), Bjoern Menze(University of Zurich), Olaf Ronneberger(Google DeepMind (United Kingdom)), Ronald M. Summers(National Institutes of Health Clinical Center), Bram van Ginneken(Radboud University Nijmegen), Michel Bilello(University of Pennsylvania), Patrick Bilic(Technical University of Munich), Patrick Ferdinand Christ(Technical University of Munich), Richard Kinh Gian(Memorial Sloan Kettering Cancer Center), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Stephan Heckers(Vanderbilt University Medical Center), Henkjan Huisman(Radboud University Nijmegen), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Maureen McHugo(Vanderbilt University Medical Center), Sandy Napel(Stanford University), Jennifer S. Golia Pernicka(Memorial Sloan Kettering Cancer Center), Kawal Rhode(King's College London), Catalina Tobon‐Gomez(King's College London), Eugene Vorontsov(Polytechnique Montréal), James Meakin(Radboud University Nijmegen), Sébastien Ourselin(King's College London), Manuel Wiesenfarth(German Cancer Research Center), Pablo Arbeláez(Universidad de Los Andes), Byeonguk Bae, Sihong Chen(Tencent (China)), Laura Daza(Universidad de Los Andes), Jianjiang Feng(Tsinghua University), Baochun He(Chinese Academy of Sciences), Fabian Isensee(German Cancer Research Center), Yuanfeng Ji(Xiamen University), Fucang Jia(Chinese Academy of Sciences), Ildoo Kim, Klaus Maier‐Hein(Heidelberg University), Dorit Merhof(Fraunhofer Institute for Digital Medicine), Akshay Pai(University of Copenhagen), Beomhee Park, Mathias Perslev(University of Copenhagen), R. Rezaiifar, Oliver Rippel(RWTH Aachen University), Ignacio Sarasúa(German Research Centre for Artificial Intelligence), Wei Shen(Shanghai Jiao Tong University), Jaemin Son, Christian Wachinger(German Research Centre for Artificial Intelligence), Liansheng Wang(Xiamen University), Yan Wang(East China Normal University), Yingda Xia(Johns Hopkins University), Daguang Xu(Nvidia (United States)), Zhanwei Xu(Tsinghua University), Yefeng Zheng(Tencent (China)), Amber L. Simpson(Queen's University), Lena Maier‐Hein(German Cancer Research Center), M. Jorge Cardoso(King's College London)
Nature Communications
July 15, 2022
Cited by 1,181Open Access
Full Text

Abstract

International challenges have become the de facto standard for comparative assessment of image analysis algorithms. Although segmentation is the most widely investigated medical image processing task, the various challenges have been organized to focus only on specific clinical tasks. We organized the Medical Segmentation Decathlon (MSD)-a biomedical image analysis challenge, in which algorithms compete in a multitude of both tasks and modalities to investigate the hypothesis that a method capable of performing well on multiple tasks will generalize well to a previously unseen task and potentially outperform a custom-designed solution. MSD results confirmed this hypothesis, moreover, MSD winner continued generalizing well to a wide range of other clinical problems for the next two years. Three main conclusions can be drawn from this study: (1) state-of-the-art image segmentation algorithms generalize well when retrained on unseen tasks; (2) consistent algorithmic performance across multiple tasks is a strong surrogate of algorithmic generalizability; (3) the training of accurate AI segmentation models is now commoditized to scientists that are not versed in AI model training.


Related Papers

No related papers found

Powered by citation graph analysis